{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:23:45Z","timestamp":1789554225726,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.4158\/ep13114.ra","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T21:01:43Z","timestamp":1370984503000},"page":"834-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Osteoporosis in Men"],"prefix":"10.1016","volume":"19","author":[{"given":"Nelson B.","family":"Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP13114.RA_bb0010","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.4158\/EP13114.RA_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 20052025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP13114.RA_bb0020","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jbmr.55","article-title":"Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines","volume":"25","author":"Donaldson","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP13114.RA_bb0025","series-title":"Osteoporosis in Men","first-page":"351","article-title":"Epidemiology of fractures. In: Orwoll ES, Bilezikian JP, Vanderschueren D, eds","author":"Amin","year":"2010"},{"key":"10.4158\/EP13114.RA_bb0030","first-page":"701","article-title":"Limb fractures in a defined population. I. Frequency and distribution","volume":"54","author":"Garraway","year":"1979","journal-title":"Mayo Clin Proc"},{"key":"10.4158\/EP13114.RA_bb0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF03187467","article-title":"Incidence of hip fractures in the elderly: a cross-national analysis","volume":"1","author":"Maggi","year":"1991","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP13114.RA_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/bmj.333.7557.27","article-title":"Hip fracture","volume":"333","author":"Parker","year":"2006","journal-title":"BMJ"},{"key":"10.4158\/EP13114.RA_bb0045","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1359\/jbmr.2002.17.7.1237","article-title":"International variations in hip fracture probabilities: implications for risk assessment","volume":"17","author":"Kanis","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP13114.RA_bb0050","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP13114.RA_bb0055","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00198-008-0588-0","article-title":"Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks","volume":"19","author":"Nguyen","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP13114.RA_bb0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP13114.RA_bb0065","doi-asserted-by":"crossref","first-page":"76S","DOI":"10.1016\/S0002-9343(05)80082-8","article-title":"The dilemma of osteoporosis in men","volume":"98","author":"Seeman","year":"1995","journal-title":"Am J Med"},{"key":"10.4158\/EP13114.RA_bb0070","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMcp0707217","article-title":"Osteoporosis in men","volume":"358","author":"Ebeling","year":"2008","journal-title":"N Engl J Med"},{"key":"10.4158\/EP13114.RA_bb0075","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bone.2004.11.015","article-title":"Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age","volume":"36","author":"Wang","year":"2005","journal-title":"Bone"},{"key":"10.4158\/EP13114.RA_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/ip.2004.005835","article-title":"Gender differences for nonfatal unintentional fall related injuries among older adults","volume":"11","author":"Stevens","year":"2005","journal-title":"Injury Prev"},{"key":"10.4158\/EP13114.RA_bb0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1651-2227.1980.tb07028.x","article-title":"Pubertal growth as reflected by simultaneous changes in bone mineral content and serum alkaline phosphatase","volume":"69","author":"Krabbe","year":"1980","journal-title":"Acta Paediatr Scand"},{"key":"10.4158\/EP13114.RA_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01623429","article-title":"Peak bone mass","volume":"4(Supp. 1):","author":"Bonjour","year":"1994","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP13114.RA_bb0095","series-title":"Osteoporosis in Men","first-page":"167","article-title":"Age-related changes in bone remodeling and microarchitecture. In: Orwoll ES, Bilezikian JP, Vanderschueren D, eds","author":"Zebaze","year":"2010"},{"key":"10.4158\/EP13114.RA_bb0100","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1359\/jbmr.040916","article-title":"Population- based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites","volume":"19","author":"Riggs","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP13114.RA_bb0105","series-title":"Osteoporosis in Men","first-page":"193","article-title":"Changes in bone size and geometry with aging. In: Orwoll ES, Bilezikian JP, Vanderschueren D, eds","author":"Szulc","year":"2010"},{"key":"10.4158\/EP13114.RA_bb0110","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen- receptor gene in a man","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med"},{"key":"10.4158\/EP13114.RA_bb0115","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199808273390905","article-title":"Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency","volume":"339","author":"Bilezikian","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4158\/EP13114.RA_bb0120","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2009-0206","article-title":"The effects of serum testosterone, estradiol, and sex hormone bindingglobulin levels on fracture risk in men","volume":"94","author":"LeBlanc","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13114.RA_bb0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2002-021036","article-title":"Differential effects of androgens and estrogens on bone turnover in normal men","volume":"88","author":"Leder","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13114.RA_bb0130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3945\/ajcn.2008.26182","article-title":"Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2005","volume":"88","author":"Looker","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.4158\/EP13114.RA_bb0135","series-title":"The Parathyroids","first-page":"835","article-title":"Parathyroid function in the normal aging process. In: Bilezikian JP, Marcus R, Levine MA, eds","author":"Khosla","year":"2003"},{"key":"10.4158\/EP13114.RA_bb0140","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: an Endocrine Society clinical practice guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13114.RA_bb0145","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nrrheum.2012.154","article-title":"Bone: New guidelines for multistep fracture prevention in men","volume":"8","author":"Geusens","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.4158\/EP13114.RA_bb0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jocd.2007.12.009","article-title":"Dual-Energy X-ray Absorptiometry Technical issues: the 2007 ISCD Official Positions","volume":"11","author":"Simonelli","year":"2008","journal-title":"J Clin Densitom"},{"key":"10.4158\/EP13114.RA_bb0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1385\/JCD:2:3:211","article-title":"Understanding the Bone Mass Measurement Act","volume":"2","author":"Watts","year":"1999","journal-title":"J Clin Densitom"},{"key":"10.4158\/EP13114.RA_bb0160","series-title":"Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis","year":"2013"},{"key":"10.4158\/EP13114.RA_bb0165","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis -- where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.4158\/EP13114.RA_bb0170","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13114.RA_bb0175","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N Engl J Med"},{"key":"10.4158\/EP13114.RA_bb0180","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/01.ju.0000063820.94994.95","article-title":"Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"key":"10.4158\/EP13114.RA_bb0185","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1359\/jbmr.090818","article-title":"Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis","volume":"24","author":"Watts","year":"2009","journal-title":"J Bone Miner Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2044652X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2044652X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/Y8261U6VJHH72760.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:55:35Z","timestamp":1761515735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2044652X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1530891X2044652X"],"URL":"https:\/\/doi.org\/10.4158\/ep13114.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis in Men","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP13114.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}